Abnormal Glucose Metabolism Parameters and the Aggressiveness of Differentiated Thyroid Carcinoma: A Hospital-Based Cross-Section Study in China

Junyu Zhao, Yutian Tian, Zhen Jia, Jinming Yao, Lin Liao, Jianjun Dong, Junyu Zhao, Yutian Tian, Zhen Jia, Jinming Yao, Lin Liao, Jianjun Dong

Abstract

Purpose: The correlation of abnormal glucose metabolism and thyroid carcinoma, especially the aggressiveness of thyroid cancer, still remains controversial. We conducted this study to investigate the relationship between abnormal glucose metabolism parameters and differentiated thyroid carcinoma (DTC) in the Chinese population.

Materials and methods: The study was designed as a hospital-based case-control study and was approved by the Ethics Committee of our hospital and registered in the Clinical Trial Protocol Registration and Results System (Registration code: NCT03006289). From January 1, 2018 to June 30, 2021, a total of 377 DTC patients were enrolled in the study. Demographic and general characteristics, details of thyroid surgery and histopathological results, hematological test indicators were collected. Glucose metabolism parameters were calculated. Variables were analyzed by t-test, ANOVA, chi-squared analysis and Fisher's exact test. Pearson bi-variate correlation and Spearman's correlation analysis were used for bi-variate analysis.

Results: More than 40% of patients with DTC were multifocality, more than half were extra-glandular invasion, and nearly 85% complied by lymph node metastasis. The prevalence of diabetes mellitus (DM) was about 10.08% in DTC patients. It was found that the proportion of postprandial 2 h blood glucose ≥11.1mmol/L and HbA1c ≥6.5% was significantly higher than the known proportion of DM (17.8%, 16.7% vs. 10.08%). Additionally, 87.3% of the DTC patients in this study had varying degrees of insulin resistance. Further analysis found that higher T staging was associated with higher levels of area under curve of C-peptide (P = 0.029), insulin sensitivity index (P = 0.012) and C-peptide sensitivity index (P = 0.016). A delayed peak of insulin secretion was found to be positive related with capsule invasion (r = 0.206, P = 0.004). In patients without a DM history, homeostasis model assessment of insulin resistance (P = 0.017), insulin sensitivity index (P = 0.019) and C-peptide sensitivity index (P = 0.020) were statistic associated with T staging. Also, the glucose metabolism parameter at 3-hour after a meal was related to a larger number of metastatic lymph nodes.

Conclusion: Abnormal glucose metabolism, namely, DM, hyperinsulinemia and insulin resistance, were significantly associated with the carcinogensis and aggressiveness of DTC.

Keywords: area under curve; differentiated thyroid carcinoma; homeostasis model assessment of insulin resistance; insulin resistance; insulin sensitivity index.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2022 Zhao, Tian, Jia, Yao, Liao and Dong.

Figures

Figure 1
Figure 1
Correlation between ISI, CSI and T staging. (A) ISI in all patients. (B) ISI in patients without DM. (C) CSI in all patients. (D) CSI in patients without DM.

References

    1. Davies L, Hoang JK. Thyroid Cancer in the USA: Current Trends and Outstanding Questions. Lancet Diabetes Endocrinol (2021) 9(1):11–2. doi: 10.1016/S2213-8587(20)30372-7
    1. Wang J, Yu F, Shang Y, Ping Z, Liu L. Thyroid Cancer: Incidence and Mortality Trends in China, 2005-2015. Endocrine (2020) 68(1):163–73. doi: 10.1007/s12020-020-02207-6
    1. Junyu Z. Association Between Hypercholesterol and Risk of Differentiated Thyroid Cancer and Its Mechanism. [Master’s Thesis]. Shandong: Shandong University; (2020).
    1. Fagin JA, Wells SA., Jr. Biologic and Clinical Perspectives on Thyroid Cancer. N Engl J Med (2016) 375(11):1054–67. doi: 10.1056/NEJMra1501993
    1. Dal Maso L, Bosetti C, La Vecchia C, Franceschi S. Risk Factors for Thyroid Cancer: An Epidemiological Review Focused on Nutritional Factors. Cancer Causes Control (2009) 20(1):75–86. doi: 10.1007/s10552-008-9219-5
    1. NCD Risk Factor Collaboration (NCD-RisC) . Trends in Adult Body-Mass Index in 200 Countries From 1975 to 2014: A Pooled Analysis of 1698 Population-Based Measurement Studies With 19.2 Million Participants. Lancet (2016) 387(10026):1377–96. doi: 10.1016/S0140-6736(16)30054-X
    1. Kitahara CM, Platz EA, Freeman LE, Hsing AW, Linet MS, Park Y, et al. . Obesity and Thyroid Cancer Risk Among U.S. Men and Women: A Pooled Analysis of Five Prospective Studies. Cancer Epidemiol Biomarkers Prev (2011) 20(3):464–72. doi: 10.1158/1055-9965.EPI-10-1220
    1. Kim WG, Park JW, Willingham MC, Cheng SY. Diet-Induced Obesity Increases Tumor Growth and Promotes Anaplastic Change in Thyroid Cancer in a Mouse Model. Endocrinology (2013) 154(8):2936–47. doi: 10.1210/en.2013-1128
    1. Duran AO, Anil C, Gursoy A, Nar A, Altundag O, Tutuncu NB. The Relationship Between Glucose Metabolism Disorders and Malignant Thyroid Disease. Int J Clin Oncol (2013) 18(4):585–9. doi: 10.1007/s10147-012-0435-3
    1. Chen ST, Hsueh C, Chiou WK, Lin JD. Disease-Specific Mortality and Secondary Primary Cancer in Well-Differentiated Thyroid Cancer With Type 2 Diabetes Mellitus. PloS One (2013) 8(1):e55179. doi: 10.1371/journal.pone.0055179
    1. Rezzónico JN, Rezzónico M, Pusiol E, Pitoia F, Niepomniszcze H. Increased Prevalence of Insulin Resistance in Patients With Differentiated Thyroid Carcinoma. Metab Syndr Relat Disord (2009) 7(4):375–80. doi: 10.1089/met.2008.0062
    1. Bae MJ, Kim SS, Kim WJ, Yi YS, Jeon YK, Kim BH, et al. . High Prevalence of Papillary Thyroid Cancer in Korean Women With Insulin Resistance. Head Neck (2016) 38(1):66–71. doi: 10.1002/hed.23848
    1. Heidari Z, Abdani M, Mansournia MA. Insulin Resistance Associated With Differentiated Thyroid Carcinoma: Penalized Conditional Logistic Regression Analysis of a Matched Case-Control Study Data. Int J Endocrinol Metab (2017) 16(1):e14545. doi: 10.5812/ijem.14545
    1. Balkan F, Onal ED, Usluogullari A, Tuzun D, Ozdemir D, Inancli SS, et al. . Is There Any Association Between Insulin Resistance and Thyroid Cancer?: A Case Control Study. Endocrine (2014) 45(1):55–60. doi: 10.1007/s12020-013-9942-x
    1. Wang F, Yu X, Shen X, Zhu G, Huang Y, Liu R, et al. . The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer. J Clin Endocrinol Metab (2017) 102(9):3241–50. doi: 10.1210/jc.2017-00277
    1. Qu N, Zhang L, Ji QH, Zhu YX, Wang ZY, Shen Q, et al. . Number of Tumor Foci Predicts Prognosis in Papillary Thyroid Cancer. BMC Cancer (2014) 14:914. doi: 10.1186/1471-2407-14-914
    1. Kim HJ, Sohn SY, Jang HW, Kim SW, Chung JH. Multifocality, But Not Bilaterality, Is a Predictor of Disease Recurrence/Persistence of Papillary Thyroid Carcinoma. World J Surg (2013) 37(2):376–84. doi: 10.1007/s00268-012-1835-2
    1. Chen L, Zhu Y, Zheng K, Zhang H, Guo H, Zhang L, et al. . The Presence of Cancerous Nodules in Lymph Nodes Is a Novel Indicator of Distant Metastasis and Poor Survival in Patients With Papillary Thyroid Carcinoma. J Cancer Res Clin Oncol (2017) 143(6):1035–42. doi: 10.1007/s00432-017-2345-2
    1. Chinese Diabetes Society . Guideline for the Prevention and Treatment of Type 2 Diabetes Mellitus in China (2020 Edition). Chin J Diabetes Mellitus (2021) 13(04):315–409. doi: 10.3760/cma.j.cn115791-20210221-00095
    1. Guraya SY. Association of Type 2 Diabetes Mellitus and the Risk of Colorectal Cancer: A Meta-Analysis and Systematic Review. World J Gastroenterol (2015) 21(19):6026–31. doi: 10.3748/wjg.v21.i19.6026
    1. Larsson SC, Orsini N, Wolk A. Diabetes Mellitus and Risk of Colorectal Cancer: A Meta-Analysis. J Natl Cancer Inst (2005) 97(22):1679–87. doi: 10.1093/jnci/dji375
    1. Wang Y, Wang B, Yan S, Shen F, Cao H, Fan J, et al. . Type 2 Diabetes and Gender Differences in Liver Cancer by Considering Different Confounding Factors: A Meta-Analysis of Cohort Studies. Ann Epidemiol (2016) 26(11):764–72. doi: 10.1016/j.annepidem.2016.09.006
    1. Larsson SC, Mantzoros CS, Wolk A. Diabetes Mellitus and Risk of Breast Cancer: A Meta-Analysis. Int J Cancer (2007) 121(4):856–62. doi: 10.1002/ijc.22717
    1. Li H, Qian J. Association of Diabetes Mellitus With Thyroid Cancer Risk: A Meta-Analysis of Cohort Studies. Med (Baltimore) (2017) 96(47):e8230. doi: 10.1097/MD.0000000000008230
    1. Grimmichova T, Haluzik M, Vondra K, Matucha P, Hill M. Relations of Prediabetes and Type 2 Diabetes to the Thyroid Cancer. Endocr Connect (2020) 9(7):607–16. doi: 10.1530/EC-20-0180
    1. Seo YG, Choi HC, An AR, Park DJ, Park YJ, Lee KE, et al. . The Association Between Type 2 Diabetes Mellitus and Thyroid Cancer. J Diabetes Res (2017) 2017:5850879. doi: 10.1155/2017/5850879
    1. Shih SR, Chiu WY, Chang TC, Tseng CH. Diabetes and Thyroid Cancer Risk: Literature Review. Exp Diabetes Res (2012) 2012:578285. doi: 10.1155/2012/578285
    1. Wu JW, Azoulay L, Majdan A, Boivin JF, Pollak M, Suissa S. Long-Term Use of Long-Acting Insulin Analogs and Breast Cancer Incidence in Women With Type 2 Diabetes. J Clin Oncol (2017) 35(32):3647–53. doi: 10.1200/JCO.2017.73.4491
    1. Sheng X, Yao K, Shao A, Tu S, Zhang X, Chen T, et al. . The Role of Insulin Glargine and Human Insulin in the Regulation of Thyroid Proliferation Through Mitogenic Signaling. Front Endocrinol (Lausanne) (2019) 10:594. doi: 10.3389/fendo.2019.00594
    1. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, et al. . Circulating Concentrations of Insulin-Like Growth Factor-I and Risk of Breast Cancer. Lancet (1998) 351(9113):1393–6. doi: 10.1016/S0140-6736(97)10384-1
    1. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, et al. . Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF-Binding Protein-3. J Natl Cancer Inst (1999) 91(7):620–5. doi: 10.1093/jnci/91.7.620
    1. Clemmons DR. Structural and Functional Analysis of Insulin-Like Growth Factors. Br Med Bull (1989) 45(2):465–80. doi: 10.1093/oxfordjournals.bmb.a072335
    1. Tramontano D, Cushing GW, Moses AC, Ingbar SH. Insulin-Like Growth Factor-I Stimulates the Growth of Rat Thyroid Cells in Culture and Synergizes the Stimulation of DNA Synthesis Induced by TSH and Graves’-IgG. Endocrinology (1986) 119(2):940–2. doi: 10.1210/endo-119-2-940
    1. Boyle P, Koechlin A, Pizot C, Boniol M, Robertson C, Mullie P, et al. . Blood Glucose Concentrations and Breast Cancer Risk in Women Without Diabetes: A Meta-Analysis. Eur J Nutr (2013) 52(5):1533–40. doi: 10.1007/s00394-012-0460-z
    1. Siddique A, Kowdley KV. Insulin Resistance and Other Metabolic Risk Factors in the Pathogenesis of Hepatocellular Carcinoma. Clin Liver Dis (2011) 15(2):281–96, vii-x. doi: 10.1016/j.cld.2011.03.007
    1. Gursoy A. Rising Thyroid Cancer Incidence in the World Might be Related to Insulin Resistance. Med Hypotheses (2010) 74(1):35–6. doi: 10.1016/j.mehy.2009.08.021
    1. Mittal A, Poudel B, Pandeya DR, Gupta SP, Sathian B, Yadav SK. Metabolic Changes Enhance the Cardiovascular Risk With Differentiated Thyroid Carcinoma–A Case Control Study From Manipal Teaching Hospital of Nepal. Asian Pac J Cancer Prev (2012) 13(5):2335–8. doi: 10.7314/apjcp.2012.13.5.2335
    1. Sahin M, Uçan B, Giniş Z, Topaloğlu O, Güngüneş A, Bozkurt NÇ, et al. . Vitamin D3 Levels and Insulin Resistance in Papillary Thyroid Cancer Patients. Med Oncol (2013) 30(2):589. doi: 10.1007/s12032-013-0589-5
    1. Giusti M, Mortara L, Degrandi R, Cecoli F, Mussap M, Rodriguez G, et al. . Metabolic and Cardiovascular Risk in Patients With a History of Differentiated Thyroid Carcinoma: A Case-Controlled Cohort Study. Thyroid Res (2008) 1(1):2. doi: 10.1186/1756-6614-1-2
    1. Akker M, Güldiken S, Sipahi T, Palabıyık O, Tosunoğlu A, Çelik Ö, et al. . Investigation of Insulin Resistance Gene Polymorphisms in Patients With Differentiated Thyroid Cancer. Mol Biol Rep (2014) 41(5):3541–7. doi: 10.1007/s11033-014-3218-2
    1. Ucan B, Sahin M, Kizilgul M, Ozbek M, Ozdemir S, Calıskan M, et al. . Serum Ghrelin Levels in Papillary Thyroid Carcinoma. Arch Endocrinol Metab (2017) 61(5):464–9. doi: 10.1590/2359-3997000000290
    1. Elbasan O, Yavuz DG. Effects of Concomitant Obesity and Diabetes on the Aggressiveness and Outcomes of Differentiated Thyroid Cancer Patients. Arch Endocrinol Metab (2021) 65 (4):455–61. doi: 10.20945/2359-3997000000361
    1. Guo X, Chen X, Zhang C, Zhang J, Zhang C. Hyperinsulinemia and Thyroid Peroxidase Antibody in Chinese Patients With Papillary Thyroid Cancer. Endocr J (2019) 66(8):731–7. doi: 10.1507/endocrj.EJ18-0358

Source: PubMed

3
Abonnieren